EXICURE, INC. Income (Loss) Attributable to Parent, before Tax
EXICURE, INC. (XCUR) reported Income (Loss) Attributable to Parent, before Tax of -$23.53 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2021-11-19
- EXICURE, INC. income (loss) attributable to parent, before tax for the quarter ending 2021-09-30 was -$23.53M.
- EXICURE, INC. income (loss) attributable to parent, before tax for the quarter ending 2021-06-30 was -$14.27M.
- EXICURE, INC. income (loss) attributable to parent, before tax for the quarter ending 2021-03-31 was -$12.48M, a 1184.96% decline year-over-year.
- EXICURE, INC. income (loss) attributable to parent, before tax for the quarter ending 2020-09-30 was -$8.82M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 9 month |
|---|---|---|---|
| 2021-09-30 | -$23.53M 10-Q · filed 2021-11-19 | -$37.80M derived: sum of 2 quarters · filed 2021-11-19 | -$50.28M 10-Q · filed 2021-11-19 |
| 2021-06-30 | -$14.27M 10-Q · filed 2021-08-12 | -$26.75M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$12.48M 10-Q · filed 2021-05-12 | ||
| 2020-09-30 | -$8.82M 10-Q · filed 2021-11-19 | -$13.13M derived: sum of 2 quarters · filed 2021-11-19 | -$11.98M 10-Q · filed 2021-11-19 |
| 2020-06-30 | -$4.31M 10-Q · filed 2021-08-12 | -$3.16M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $1.15M 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |